Skip to main content

Table 2 Pre-treatment Clinical Risk Assessment

From: Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

Clinical Risk Assessment (based on pre-treatment assessment)

Low Risk (All of the below)

High Risk (Any of the below)

T0-T3

T4

N0-N1

N2-3 (or nodal conglomerate \(\ge\) 6 cm)

\(\le\) 20 pack year smoking history

 > 20 pack year smoking history

HPV16 subtype

HPV18 subtype